XRCC2 and colorectal cancer: The most notable and frequent included NEIL3, XRCC2, CCNO, RAD54L, ATM, DDB2, and MSH2, all of which have been linked to treatment resistance in glioma or solid tumours such as colorectal cancer [10,26,33,34,35,36,37,38].